Our results confirm this framework and extend it by providing a molecular basis for this feedback, where RBL1 is not only a functional compensator for RB loss, but also directly regulated by the same network that enforces cell cycle arrest via p53 and p21, thus integrating it into the broader tumor suppressor circuitry. The gene discussed is CDKN1A; the disease is neoplasm.